Broadway Pedigree Alchemation has a proven track record anchored by founder Kevin McCollum, with productions on Broadway, the West End, and national tours, positioning it as a magnet for investors, sponsors, and talent partnerships. Current Broadway projects include SIX and Mrs. Doubtfire, with additional works in development like The Notebook and The Devil Wears Prada, and an Off-Broadway engagement of Oh, Mary! in December 2023, signaling a scalable pipeline for co-productions and licensing opportunities.

Strong Pipeline A robust slate of new works in development alongside ongoing Broadway and Off-Broadway engagements suggests multiple monetization paths, including development funding, commission deals, licensing, and potential streaming or rights sales as projects mature.

Strategic Partnerships Existing collaborations with Mike & Carlee Productions demonstrate a propensity for co-productions and joint ventures. This opens doors to sponsor relationships, investor networks, talent agency connections, and cross-promotional campaigns that can accelerate fundraising and market reach.

Digital & Tech The company uses a modern digital stack (iCIMS, Squarespace, Squarespace Commerce, Stimulus, and related tools), presenting opportunities to optimize talent recruitment, online merchandising, ticketing or content distribution, and data-driven marketing for scalable productions.

Growth Funding With modest revenue and existing early-stage funding, there is an opening to engage production financiers, grant programs, and strategic sponsors, as well as to craft compelling investment narratives and IP-driven packaging for future projects.